Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty

Drug-eluting balloon percutaneous transluminal angioplasty significantly prolonged 6-month and 1-year lesion primary patency and 6-month circuit primary patency in patients with hemodialysis access stenosis when compared those in patients who underwent conventional balloon percutaneous transluminal angioplasty.